THE VIEW FROM HERE
New Hepatitis C Drug, Old Problems
By Christopher F. Koller
President of the Milbank Memorial Fund
Every once in a while, an issue comes along that serves up so clearly the conflict between a societal desire to maximize medical care treatment choices and the reality of limited resources that people say, “Maybe this is the one that will provoke the hard conversations.” Enter Sovaldi for the treatment of Hepatitis C.